Results 201 to 210 of about 24,212 (246)

5-hydroxytryptamine is a mediator of 4-aminopyridine induced contractions in porcine and human isolated coronary arteries [PDF]

, 2000
Attila Kun, János Pataricza, Irén Krassói, Miklós Opincariu, Jànos Szécsi, Julius Gy   +5 more
openalex  

Synthesis and pharmacology of 4-aminopyridine derivatives

, 1987
Petrus Theodorus Maria Biessels
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

4-Aminopyridine kinetics

Clinical Pharmacology and Therapeutics, 1982
Nine healthy subjects (7 men; 2 women) received single 20-mg IV injections of 4-aminopyridine (4-AP). Six of the subjects received the same dose in the form of enteric-coated tablets and four the same dose in uncoated tablets; treatments were at least 2 wk apart.
UGES, DRA, SOHN, YJ, GREIJDANUS, B, SCAF, AHJ, AGOSTON, S   +4 more
openaire   +3 more sources

INDO theoretical studies of 4-aminopyridine and protonated 4-aminopyridine

Journal of the Chemical Society, Perkin Transactions 2, 1975
Geometry optimized INDO calculations have been performed on 4-aminopyridine (2) and protonated 4-aminopyridine (1) in order to compare their optimized geometries, π-bond orders, C(4)–NH2 rotational barriers, charge densities, and π-electron distributions. It had previously been shown that 4-aminopyridine falls far off a linear correlation of ΔG° and ΔS°
Charles U. Pittman, Onallah M. Attallah, Lowell D. Kispert   +2 more
openaire   +1 more source

Facile synthesis of functionalized 4-aminopyridines

Chemical Communications, 2002
AbstractFor Abstract see ChemInform Abstract in Full Text.
Nagatoshi, Nishiwaki, Mayumi, Azuma, Mina, Tamura, Kazushige, Hori, Yasuo, Tohda, Masahiro, Ariga   +5 more
openaire   +2 more sources

Alkylation of 4-aminopyridine

Chemistry of Heterocyclic Compounds, 1971
4-Alkylaminopyridines are formed by the alkylation of 4-aminopyridine with cyclohexanol, cyclopentanol, and 2-propanol in sulfuric acid.
S. I. Burmistrov, A. V. Krasovskii
openaire   +1 more source

4‐Aminopyridine in multiple sclerosis

Neurology, 1991
In an earlier study, we demonstrated efficacy of single oral doses of 4-aminopyridine (4-AP) in improving motor and visual signs in multiple sclerosis (MS) patients for a mean of 4.97 hours. We attempted to determine whether efficacy could safely be prolonged using multiple daily doses over several days by administering 7.5 to 52.5 mg 4-AP to 17 ...
D, Stefoski, F A, Davis, W E, Fitzsimmons, S S, Luskin, J, Rush, G W, Parkhurst   +5 more
openaire   +2 more sources

Characterization of 4-Aminopyridine in Overdose

Journal of Toxicology: Clinical Toxicology, 1994
We report three cases of 4-aminopyridine overdose resulting in seizure activity. All patients were on therapeutic regimens for the treatment of multiple sclerosis. All patients were responsive to intensive supportive care, although the length of toxicity was prolonged more than 24 hours in one patient.
C M, Stork, R S, Hoffman
openaire   +2 more sources

Pharmacokinetics of 4-aminopyridine in horses

American Journal of Veterinary Research, 1984
SUMMARY The pharmacokinetics of 4-aminopyridine (4-ap), a drug capable of antagonizing nondepolarizing neuromuscular blocking drugs, as well as several classes of injectable sedative and anesthetic agents, were studied in 6 intact, awake horses. Plasma samples were assayed for 4-ap over a frequent sampling schedule for 8 hours after iv administration ...
J V, Kitzman, R C, Wilson, N H, Booth, H L, Hendricks, P B, Bush   +4 more
openaire   +2 more sources